We would like to provide you with an update on current projects, look back to a very successful year 2024 and give you an outlook on 2025. After the assembly, we look forward to a get-together for mutual exchange. The get-together is kindly supported by AbbVie and ULLRICH&NAUMANN.
Registration for bioRN members only.
Please contact: Sibylle Geilenberg, email:sg@biorn.org
register now
Heidelberg, Germany, November 6, 2024 – The technology transfer platform InnovationLab is looking forward to the premiere of a new event format: hydrogen experts from Germany and abroad are expected to attend the Clean Tech Innovation Day on Monday, November 11 (9 a.m. to 6 p.m.). Together with its two co-partners, the Rhine-Neckar metropolitan region […]
An international research team led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the Medical Faculties of Heidelberg University, in Mannheim and Heidelberg, has studied the different cell types in so-called subcortical lesions, tissue damage to deep brain structures, at different stages of multiple sclerosis (MS) and investigated how they communicate. In […]
Partnership to Combine AbbVie’s Oncology Expertise with EvolveImmune’s Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer NORTH CHICAGO, Ill. and BRANFORD, Conn., Oct. 31, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) and EvolveImmune Therapeutics, an immuno-oncology company developing next-generation biotherapeutics to overcome the therapeutic challenges of cancer cell resistance to current immunotherapies, today announced a collaboration […]
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
